PERNIX THERAPEUTICS HLDGS IN's ticker is PTX and the CUSIP is 71426V108.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $5,000 | +66.7% | 7,631 | 0.0% | 0.00% | – |
| Q2 2016 | $3,000 | -98.9% | 7,631 | -96.9% | 0.00% | – |
| Q1 2016 | $261,000 | -27.5% | 248,675 | +103.7% | 0.00% | – |
| Q4 2015 | $360,000 | -5.0% | 122,050 | +1.8% | 0.00% | – |
| Q3 2015 | $379,000 | +142.9% | 119,883 | +355.2% | 0.00% | – |
| Q2 2015 | $156,000 | -26.1% | 26,338 | +33.1% | 0.00% | – |
| Q1 2015 | $211,000 | +34.4% | 19,782 | +18.3% | 0.00% | – |
| Q4 2014 | $157,000 | +15.4% | 16,725 | -5.7% | 0.00% | – |
| Q3 2014 | $136,000 | -16.6% | 17,739 | -2.2% | 0.00% | – |
| Q2 2014 | $163,000 | +120.3% | 18,145 | +31.1% | 0.00% | – |
| Q1 2014 | $74,000 | +124.2% | 13,838 | +7.2% | 0.00% | – |
| Q4 2013 | $33,000 | +10.0% | 12,903 | +17.0% | 0.00% | – |
| Q3 2013 | $30,000 | -21.1% | 11,031 | +5.2% | 0.00% | – |
| Q2 2013 | $38,000 | – | 10,485 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|